Pier-Luigi Lollini

21PUBLICATIONS
57CO-AUTHORS
Cancer geneticsMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Disease surveillanceSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Feb 26, 2025
Chondrosarcoma: New Molecular Insights, Challenges in Near-Patient Preclinical Modeling, and Therapeutic Approaches.

Lorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini

|Dec 05, 2024
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations.

Alessandro Di Federico, Stefania Angelicola, Mariateresa Frascino

|Feb 09, 2024
IL-1 Family Members in Bone Sarcomas.

Lorena Landuzzi, Francesca Ruzzi, Evelin Pellegrini

|Dec 05, 2023
Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages.

Maria Cristina Manara, Cristina Manferdini, Camilla Cristalli

|Aug 26, 2023
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy.

Francesca Ruzzi, Maria Sofia Semprini, Laura Scalambra

|Aug 12, 2023
Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma.

Lorena Landuzzi, Maria Cristina Manara, Laura Pazzaglia

Pageof 4